Ferrell Betty, Sun Virginia, Hurria Arti, Cristea Mihaela, Raz Dan J, Kim Jae Y, Reckamp Karen, Williams Anna Cathy, Borneman Tami, Uman Gwen, Koczywas Marianna
Division of Nursing Research and Education, Department of Population Sciences, City of Hope, Duarte, California, USA.
Division of Nursing Research and Education, Department of Population Sciences, City of Hope, Duarte, California, USA.
J Pain Symptom Manage. 2015 Dec;50(6):758-67. doi: 10.1016/j.jpainsymman.2015.07.005. Epub 2015 Aug 19.
Palliative care, including symptom management and attention to quality of life (QOL) concerns, should be addressed throughout the trajectory of a serious illness such as lung cancer.
This study tested the effectiveness of an interdisciplinary palliative care intervention for patients with Stage I-IV non-small cell lung cancer (NSCLC).
Patients undergoing treatments for NSCLC were enrolled in a prospective, quasi-experimental study whereby the usual care group was accrued first followed by the intervention group. Patients in the intervention group were presented at interdisciplinary care meetings, and appropriate supportive care referrals were made. They also received four educational sessions. In both groups, QOL, symptoms, and psychological distress were assessed at baseline and 12 weeks using surveys which included the Functional Assessment of Cancer Therapy-Lung and the Lung Cancer Subscale, the 12-item Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being, and the Distress Thermometer.
A total of 491 patients were included in the primary analysis. Patients who received the intervention had significantly better scores for QOL (109.1 vs. 101.4; P < 0.001), symptoms (25.8 vs. 23.9; P < 0.001) spiritual well-being (38.1 vs. 36.2; P = 0.001), and lower psychological distress (2.2 vs. 3.3; P < 0.001) at 12 weeks, after controlling for baseline scores, compared to patients in the usual care group. Patients in the intervention group also had significantly higher numbers of completed advance care directives (44% vs. 9%; P < 0.001), and overall supportive care referrals (61% vs. 28%; P < 0.001). The benefits were seen primarily in the earlier stage patients vs. those with Stage IV disease.
Interdisciplinary palliative care in the ambulatory care setting resulted in significant improvements in QOL, symptoms, and distress for NSCLC patients.
姑息治疗,包括症状管理和对生活质量(QOL)问题的关注,应在肺癌等严重疾病的整个病程中得到解决。
本研究测试了一种跨学科姑息治疗干预措施对I-IV期非小细胞肺癌(NSCLC)患者的有效性。
接受NSCLC治疗的患者被纳入一项前瞻性、准实验性研究,先招募常规护理组,然后是干预组。干预组患者参加跨学科护理会议,并进行适当的支持性护理转诊。他们还接受了四次教育课程。两组患者在基线和12周时使用包括癌症治疗功能评估-肺癌和肺癌子量表、慢性病治疗功能评估-精神健康12项量表以及痛苦温度计在内的调查问卷评估生活质量、症状和心理困扰。
共有491名患者纳入初步分析。在控制基线分数后,与常规护理组患者相比,接受干预的患者在12周时生活质量(109.1对101.4;P<0.001)、症状(25.8对23.9;P<0.001)、精神健康(38.1对36.2;P = 0.001)得分显著更高,心理困扰更低(2.2对3.3;P<0.001)。干预组患者完成预先医疗指示的数量也显著更多(44%对9%;P<0.001),总体支持性护理转诊率也更高(61%对28%;P<0.001)。这些益处主要见于早期患者与IV期疾病患者相比。
门诊环境中的跨学科姑息治疗使NSCLC患者的生活质量、症状和困扰得到显著改善。